The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Zinda Michael since 2020.
This trader's CIK number is 1815366.
At the time of last reporting, Zinda Michael was the EVP, CHIEF SCIENTIFIC OFFICER of Repare Therapeutics Inc.. (stock ticker symbol RPTX).
Also see all insider trading activities at Repare Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RPTX | 0 | $0 | 5,611 | $6,396 | 0 | $0 |
| 2024 | RPTX | 0 | $0 | 2,210 | $10,302 | 0 | $0 |
| 2023 | RPTX | 0 | $0 | 10,473 | $125,972 | 0 | $0 |
| 2022 | RPTX | 0 | $0 | 533 | $6,022 | 0 | $0 |
| 2021 | RPTX | 0 | $0 | 35,000 | $1,063,850 | 46,041 | $89,319 |
| 2020 | RPTX | 0 | $0 | 150,000 | $5,081,252 | 115,304 | $239,367 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-12 | RPTX | Sale | 5,611 | 1.14 | 6,396 |
| 2024-03-28 | RPTX | Sale | 450 | 4.64 | 2,088 |
| 2024-04-01 | RPTX | Sale | 410 | 4.66 | 1,910 |
| 2024-03-25 | RPTX | Sale | 450 | 4.78 | 2,151 |
| 2024-03-26 | RPTX | Sale | 450 | 4.61 | 2,074 |
| 2024-03-27 | RPTX | Sale | 450 | 4.62 | 2,079 |
| 2023-06-08 | RPTX | Sale | 2,869 | 12.02 | 34,485 |
| 2023-06-07 | RPTX | Sale | 6,404 | 12.03 | 77,040 |
| 2023-06-06 | RPTX | Sale | 1,200 | 12.04 | 14,447 |
| 2022-03-15 | RPTX | Sale | 533 | 11.30 | 6,022 |
| 2021-11-23 | RPTX | Option Ex | 46,041 | 1.94 | 89,319 |
| 2021-11-15 | RPTX | Sale | 20,000 | 27.54 | 550,700 |
| 2021-08-16 | RPTX | Sale | 15,000 | 34.21 | 513,150 |
| 2020-12-29 | RPTX | Sale | 19,696 | 34.31 | 675,828 |
| 2020-12-28 | RPTX | Option Ex | 48 | 2.06 | 98 |
| 2020-12-28 | RPTX | Sale | 15,048 | 34.42 | 517,952 |
| 2020-12-24 | RPTX | Sale | 432 | 33.14 | 14,316 |
| 2020-12-23 | RPTX | Sale | 16,235 | 33.87 | 549,879 |
| 2020-12-24 | RPTX | Option Ex | 432 | 2.06 | 890 |
| 2020-12-22 | RPTX | Sale | 41,312 | 33.68 | 1,391,388 |
| 2020-12-23 | RPTX | Option Ex | 16,235 | 2.04 | 33,135 |
| 2020-12-22 | RPTX | Option Ex | 41,312 | 1.85 | 76,427 |
| 2020-12-21 | RPTX | Option Ex | 40,000 | 2.42 | 97,000 |
| 2020-12-21 | RPTX | Sale | 40,000 | 33.08 | 1,323,200 |
| 2020-12-18 | RPTX | Sale | 8,321 | 34.84 | 289,945 |
| 2020-12-16 | RPTX | Option Ex | 8,956 | 1.64 | 14,660 |
| 2020-12-16 | RPTX | Sale | 8,956 | 35.59 | 318,744 |
| 2020-12-18 | RPTX | Option Ex | 8,321 | 2.06 | 17,157 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zinda Michael (EVP, CHIEF SCIENTIFIC OFFICER of Repare Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.